Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tartrolon E, a secondary metabolite of a marine symbiotic bacterium, is a potent inhibitor of asexual and sexual Plasmodium falciparum

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.00684-23Source: DataRank Database

Tartrolon E, a secondary metabolite of a marine symbiotic bacterium, is a potent inhibitor of asexual and sexual Plasmodium falciparum is a research paper published in Antimicrobial Agents and Chemotherapy (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.23)OA: hybridTopics (51)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Rapatbhorn Patrapuvich ORCID,Devaraja G. Mudeppa,Sreekanth Kokkonda,Rimi Chakrabarti ORCID,Patchara Sriwichai ORCID

Live enrichment

PubMed:38193705 PMC:PMC10848769 OpenAlex:https://openalex.org/W4390768701

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: U19 AI089688

HHS | NIH | National Center for Complementary and Integrative Health

Grant: R21 AT009174

National Institutes of Health

Grant: 1R21AT009174-01

Investigation of a shipworm endosymbiont compound with activity against the AIDS-associated pathogens Cryptosporidium and Toxoplasma

National Institutes of Health

Grant: 1U19AI089688-01

Malaria Evolution in South Asia

FWCI

1.23

Citation Percentile

0.7%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1128/aac.00684-23

publisherhttps://doi.org/10.1128/aac.00684-23

publisherhttps://journals.asm.org/doi/pdf/10.1128/aac.00684-23

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38193705

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10848769

Fields of Study

Marine Sponges and Natural ProductsMalaria Research and ControlInvertebrate Immune Response MechanismsHumansPlasmodium falciparumArtemisininsAntimalarialsMalaria, FalciparumLactones

MeSH Terms

AntimalarialsHumansLactonesPlasmodium falciparumMalaria, FalciparumArtemisinins

Keywords

Plasmodium falciparumBiologySecondary metaboliteMetaboliteArtemisininBacteriaMicrobiologyCytotoxicityDrug resistanceMalariaIn vitroGeneticsBiochemistryGeneImmunologyMarine Natural ProductGametocidalShipworm SymbiontSponge-Associated Microorganisms and Biotechnological PotentialAntimalarialsLactonesBiochemistry, Genetics and Molecular BiologyHealth SciencesHumansMalaria, FalciparumSecondary MetabolitesPharmacologyImmunology and MicrobiologyFOS: Clinical medicineLife SciencesNatural Products as Sources of New DrugsArtemisininsInvertebrate Immunity and Host Defense MechanismsFOS: Biological sciencesMedicineBiotechnology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Life below water